Sentinel Lymph Node Biopsy in Breast Cancer: A Clinical Review and Update.
10.4048/jbc.2017.20.3.217
- Author:
Sheikh ZAHOOR
1
;
Altaf HAJI
;
Azhar BATTOO
;
Mariya QURIESHI
;
Wahid MIR
;
Mudasir SHAH
Author Information
1. Department of Surgical Oncology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, India. drskzahoor@rediffmail.com
- Publication Type:Review
- Keywords:
Breast neoplasms;
Lymphatic metastasis;
Neoadjuvant therapy;
Sentinel lymph node biopsy
- MeSH:
Axilla;
Breast Neoplasms*;
Breast*;
Drug Therapy;
Humans;
Lymphatic Metastasis;
Neoadjuvant Therapy;
Sentinel Lymph Node Biopsy*
- From:Journal of Breast Cancer
2017;20(3):217-227
- CountryRepublic of Korea
- Language:English
-
Abstract:
Sentinel lymph node biopsy has become a standard staging tool in the surgical management of breast cancer. The positive impact of sentinel lymph node biopsy on postoperative negative outcomes in breast cancer patients, without compromising the oncological outcomes, is its major advantage. It has evolved over the last few decades and has proven its utility beyond early breast cancer. Its applicability and efficacy in patients with clinically positive axilla who have had a complete clinical response after neoadjuvant chemotherapy is being aggressively evaluated at present. This article discusses how sentinel lymph node biopsy has evolved and is becoming a useful tool in new clinical scenarios of breast cancer management.
